ISOTRETINOIN IN THE TREATMENT OF SYSTEMIC-SCLEROSIS

被引：24

作者：

MAURICE, PDL ^{[1
]}

BUNKER, CB ^{[1
]}

DOWD, PM ^{[1
]}

机构：

[1] MIDDLESEX HOSP,DEPT DERMATOL,LONDON W1N 8AA,ENGLAND

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1989年 / 121卷 / 03期

关键词：

D O I：

10.1111/j.1365-2133.1989.tb01431.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：367 / 374

页数：8

相关论文

共 20 条

[1] ALARCONSEGOVIA D, 1974, LANCET, V1, P1054
[2] BAHMER FA, 1985, ARCH DERMATOL, V121, P308
[3] BUNKER CB, 1989, LANCET, V1, P435
[4] DALY TJ, 1986, CLIN RES, V34, pA744
[5] EPSTEIN EH, 1975, J BIOL CHEM, V250, P9304
[6] SERUM MARKERS FOR TYPE-IV COLLAGEN AND TYPE-III PROCOLLAGEN IN THE MYELOFIBROSIS-OSTEOMYELOSCLEROSIS SYNDROME AND OTHER CHRONIC MYELOPROLIFERATIVE DISORDERS
HASSELBALCH, H
JUNKER, P
LISSE, I
BENTSEN, KD
RISTELI, L
RISTELI, J
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 1986, 23 (02) : 101 - 111
[7] EFFECT OF VITAMIN-A AND ITS DERIVATIVES ON COLLAGEN PRODUCTION AND CHEMOTACTIC RESPONSE OF FIBROBLASTS
HEIN, R
MENSING, H
MULLER, PK
BRAUNFALCO, O
KRIEG, T
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (01) : 37 - 44
[8] JAYSON MIV, 1977, P ROY SOC MED, V70, P82, DOI 10.1177/00359157770700S327
[9] SERUM TYPE-III PROCOLLAGEN PEPTIDE CONCENTRATION IN CRYPTOGENIC FIBROSING ALVEOLITIS AND ITS CLINICAL RELEVANCE
KIRK, JME
BATEMAN, ED
HASLAM, PL
LAURENT, GJ
TURNERWARWICK, M
[J]. THORAX, 1984, 39 (10) : 726 - 732
[10] COLLAGEN-SYNTHESIS IN SCLERODERMA - SELECTION OF FIBROBLAST POPULATIONS DURING SUBCULTURES
KRIEG, T
PERLISH, JS
FLEISCHMAJER, R
BRAUNFALCO, O
[J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1985, 277 (05) : 373 - 376